A Randomized Multicenter Pivotal Study of CDX-011 (CR011-vcMMAE) vs capecitabine in the treatment of GNPNMC Over-expressing, Triple Negative Breast Cancer - Regional Cancer Care Associates LLC

Clinical Trials

A Randomized Multicenter Pivotal Study of CDX-011 (CR011-vcMMAE) vs capecitabine in the treatment of GNPNMC Over-expressing, Triple Negative Breast Cancer

Type of Cancer
Breast Oncology
Locations
Freehold
Howell
Sparta
Sponsor
Protocol Number
CDX011-04 METRIC
Cancer Diagnosis
To Learn More Call
201-510-0910